Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients.
Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients. Heart. 2015 Feb; 101(4):264-70.
View in:
PubMed
subject areas
Aged
Anticoagulants
Chi-Square Distribution
Female
Hemorrhage
Hospitalization
Humans
International Normalized Ratio
Logistic Models
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction
Odds Ratio
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Registries
Retrospective Studies
Risk Assessment
Risk Factors
Treatment Outcome
United States
Vitamin K
authors with profiles
Wassef Yousef Karrowni